Skip to Main Content

Insight

September 2024
Cannabis and Psychedelics Monthly Newsletter

the buzz: Cannabis News & Policy Update | September 2024

By Rachel Gillette and Jennifer Benda

Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.

This month's highlights include:

  • Where things stand on federal rescheduling (spoiler alert…moving slowly)
  • State legalization of medical cannabis in the works in Nebraska and Kentucky; adult-use in North Dakota
  • New York and California issued new compliance requirements; Rhode Island is developing adult-use license process
  • Hemp-derived products are under attack in more state litigation
  • Top Takeaways from IRS Counsel Luke Ortner at the AICPA Cannabis Conference

Read Here

Want the buzz delivered monthly?
Never miss a cannabis news and policy update. Use the button below to sign up for future monthly newsletters.

Sign Up

This publication is designed to provide general information on pertinent legal topics. The statements made are provided for educational purposes only. They do not constitute legal or financial advice nor do they necessarily reflect the views of Holland & Hart LLP or any of its attorneys other than the author(s). This publication is not intended to create an attorney-client relationship between you and Holland & Hart LLP. Substantive changes in the law subsequent to the date of this publication might affect the analysis or commentary. Similarly, the analysis may differ depending on the jurisdiction or circumstances. If you have specific questions as to the application of the law to your activities, you should seek the advice of your legal counsel.

DISCLAIMER

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.

Accept